C D Betts
Salford Royal NHS Foundation Trust
18 Papers
202 Citations
C D Betts is an academic researcher from Salford Royal NHS Foundation Trust. The author has contributed to research in topics: Transitional cell carcinoma & Bladder cancer. The author has an hindex of 8, co-authored 18 publications. Previous affiliations of C D Betts include University of Salford.
Chat about Author
Papers
•Journal Article
Prognostic relevance of micro-vessel density in cancer of the urinary bladder.
TL;DR: Microvessel density proved to be an independent prognostic marker in transitional cell carcinoma of bladder and was associated with cancer specific survival and the risk of patients dying following pelvic recurrence was significantly higher.
74
Photodynamic therapy for superficial bladder cancer under local anaesthetic
David C Shackley,C.H. Briggs,A Gilhooley,Colin Whitehurst,Kieran O’Flynn,C D Betts,James Moore,Noel W. Clarke +7 more
TL;DR: To evaluate the use of local anaesthesia in 5‐aminolaevulinic acid (ALA) photodynamic therapy for superficial transitional cell carcinoma (TCC) of the bladder, and to provide further toxicity and tolerability data on this new method within the context of a phase 1 trial.
52
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours
TL;DR: The optical properties and depth of penetration of varying wavelengths of light in ex‐vivo human bladder tissue are assessed, using specimens of normal bladder wall, transitional cell carcinoma and bladder tissue after exposure to ionizing radiation.
51
The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK
TL;DR: To assess whether the increased use of prostate‐specific antigen (PSA) testing over the last 15 years has changed the way prostate cancer presents in an inner city UK population, where PSA screening rates might be expected to be lower than in epidemiological studies based in North America.
22
The cost-effectiveness of sacral nerve stimulation (SNS) for the treatment of idiopathic medically refractory overactive bladder (wet) in the UK
TL;DR: To estimate the long‐term cost‐effectiveness of specialised treatment options for medically refractory idiopathic overactive bladder (OAB) wet, a large number of patients with OABs are randomly assigned to receive either a single or multiple treatments.
22